This paper is only available as a PDF. To read, Please Download here.
Abstract
Although there is considerable evidence that vasodilator prostaglandins such as prostaglandin
E2 (PGE2) modulate renal hemodynamics in liver cirrhosis, the role of the vasoconstrictor
thromboxane A2 (TXA2) is controversial. We measured renal hemodynamics and glomerular eicosanold production
in cirrhotic and control rats. Renal plasma flow, as estimated by para-aminohippurate clearance (CPAH) and glomerular filtration rate, as determined by inulin clearance (CIN), were comparable between groups; glomerular production of PGE2 and TXA2 (estimated by the metabolite thromboxane B2 [TXB2]) was slightly but not significantly higher in cirrhotic than in control rats (PGE2:1060 ± 142 pg/mg glomerular protein vs 854 ± 288 pg/mg glomerular protein; TXB2: 782 ± 103 pg/mg glomerular protein vs 468 ± 104 pg/mg glomerular protein). Addition
of serum from cirrhotic rats to the incubation media failed to increase eicosanold
production in glomeruli obtained from either cirrhotic or control rats. Cyclooxygenase
inhibition with 5 mg/kg indomethacin, a dose sufficient to result in a 68% inhibition
of glomerular PGE2 synthesis, decreased both CPAH (from 6.59 ± 0.69 ml/min to 4.52 ± 0.67 ml/min, p< 0.05) and CIN (from 1.34 ± 0.16 ml/min to 0.68 ± 0.07 ml/min, p < 0.01) in cirrhotic rats. Thromboxane synthesis inhibition with 1 mg/kg UK-38485,
which resulted in an 84% decrease in glomerular TXB2, did not significantly affect either CPAH or CIN; however, there was a strong trend toward improvement in CIN (from 1.23 ± 0.11 ml/mln to 1.43 ± 0.15 ml/min (0.05 < p < 0.1). Neither drug affected renal hemodynamics in control rats. Our results suggest
that, although thromboxane may play a role in the regulation of glomerular filtration
rate, the predominant effect of cyclooxygenase products in cirrhosis is to maintain
renal hemodynamics.
Abbreviations:
CIN = inulin clearance (), CPAH = para-aminohippurate clearance (), EBSS = Earle's balanced salt solution (), EDTA = ethylenediaminetetraacetic acid (), HEPES = N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid (), PAH = para-aminohippurate (), PBS = phosphate-buffered saline solution (), PGE2 = prostaglandin E2 (), TXA2 = thromboxane A2 (), TXB2 = thromboxane B2 ()To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Translational ResearchAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Role of eicosanoids in the control of renal function in severe hepatic disease.Gastroenterology. 1984; 87: 1392-1395
- Urinary thromboxane B2 in the hepatorenal syndrome: evidence for increased vasoconstrictor and decreased vasodilator factors.Gastroenterology. 1983; 84: 697-703
- Urinary excretion of 6-keto-prostaglandin F1a thromboxane B2, and prostaglandin E, in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome).J Hepatol. 1986; 3: 111-117
- Instant cirrhosis: an improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone.Br J Exp Pathol. 1969; 50: 502-506
- Arteriovenous shunting in experimental liver cirrhosis in rats.J Lab Clin Med. 1987; 109: 687-691
- Immune complex effects on glomerular eicosanoid production and renal hemodynamics.Kidney Int. 1987; 31: 1317-1326
- A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.Anal Biochem. 1978; : 206-210
- Glomerular prostaglandin and thromboxane synthesis in rat nephrotoxic serum nephritis.J Clin Invest. 1983; 72: 1439-1448
- Dynamics of ascites formation in rats with experimental cirrhosis.Am J Physiol. 1980; 238: F353-F357
- A micropuncture study of salt and water retention in chronic experimental cirrhosis.Am J Physiol. 1977; 232: F315-F318
- Decreased pressor sensitivity to angiotensin II in cirrhotic rats.Circ Res. 1985; 57: 424-431
- Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease.Gastroenterology. 1979; 77: 215-222
- Prostaglandins: modulators of renal function and pressor resistance in chronic liver disease.J Clin Endocrinol Metab. 1979; 48: 895-900
- Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship of functional renal failure and sodium and water excretion.Eur J Clin Invest. 1983; 13: 271-278
- Renal perfusion in dogs with experimental hepatic cirrhosis: role of prostaglandins.Am J Physiol. 1983; 245: F521-F529
- Importance of renal prostaglandins in control of renal function after chronic ligation of the common bile duct in dogs.J Lab Clin Med. 1984; 103: 549-559
- Role of vasopressin in impaired water excretion in conscious rats with experimental cirrhosis.Kidney Int. 1981; 20: 173-180
- Systemic and renal hemodynamics in oliguric hepatic failure: effect of volume expansion.J Clin Invest. 1967; 46: 1895-1906
- Renal prostaglandins in cirrhosis of the liver.Clin Sci. 1986; 70: 477-484
- Urinary prostaglandins in the hepatorenal syndrome of cirrhotic patients: role of thromboxane A2 and an imbalance of precursor polyunsaturated fatty acids.Gastroenterol Clin Biol. 1985; 9: 290-297
- Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome.Gastroenterology. 1984; 87: 1228-1232
- Effects of OKY 046, a thromboxane-synthase inhibitor, on renal function in nonazotemic cirrhotic patients with ascites.Gastroenterology. 1988; 94: 1470-1477
- Contractile effects of TXA2 and endoperoxide analogues on cultured rat mesangial cells.Am J Physiol. 1986; 251: F1029-F1035
Article info
Publication history
Accepted:
November 7,
1988
Received in revised form:
October 31,
1988
Received:
January 13,
1988
Footnotes
☆Supported by grants from the Veterans Administration (Research Advisory Group and Merit Review) and from Loyola University Stritch School of Medicine (Biomedical Research Support Grant).
☆☆Presented in preliminary form at the American Society of Nephrology Annual Meeting, December 1987.
Identification
Copyright
© 1989 Published by Elsevier Inc.
